1. Anderson K.E., Mardh P.A., Colleen S. (1978): Antibacterial activity and tissue distribution of Cinoxacin Curr Chemother1, 690–691.
2. Black H.R., Israel K.S., Farid K.Z., Nash J.F. (1978): Comparative pharmacology of Cinoxacin, nalidixic acid, oxolinic acid, nitrofurantoin and trimethoprimsulfamethoxazole Curr Chemother1, 203–204.
3. Black H.R., Israel K.S., Wolen R.L., Brier G.L., Obermeyer B.D., Ziege E.A., Wolny J.D. (1979): Pharmacology of Cinoxacin in humans Antimicrob Agents Chemother15, 165–170.
4. Brogard J.M., Kopferschmitt J., Spach M.O., Lavillaureix J., Grudet D. (1979): Cefuroxime: pharmacokinetics in subjects with normal and impaired renal function; prediction of serum concentrations and dosage adjustments Drugs Exptl Clin. Res.5, 427- 443.
5. Brogard J.M., Pinget M., Dorner M., Lavillaureix J. (1976): Etablissement du profil pharmacokinétique d’un antibiotique. Intérêt pratique et application à l’étude comparative des céphalosporines Bull Inst Pasteur74, 383–412.